9 April 2008
New research shows neuroprotective effect of lovastatin slows progression of Alzheimer's disease, among other benefits
High cholesterol levels are considered to be a risk factor for cardiovascular disease including stroke. Therefore, many cholesterol lowering drugs have been developed by pharmaceutical companies in recent years.
4 April 2008
Redox-Active Iron Is a Sensor of Cognitive Impairment Associated with Alzheimer's Disease
New Study Published in the Journal of Alzheimer’s Disease from the University of Chile and the International Center for Biomedicine (ICC)
7 March 2008
Increased Level Of Magnetic Iron Oxides Found In Alzheimer's Disease
A team of scientists, led by Professor Jon Dobson, of Keele University in Staffordshire, UK, have found, for the first time, raised levels of magnetic iron oxides in the part of the brain affected by Alzheimer's Disease (AD).
7 March 2008
Paradoxical Alzheimer's Finding May Shed New Light on Memory Loss
Do you remember the seventh song that played on your radio on the way to work yesterday? Most of us don’t, thanks to a normal forgetting process that is constantly “cleaning house” – culling inconsequential information from our brains.
14 January 2008
New method developed to identify genetic determinants of Alzheimer's disease
Guangzhou, China and Amsterdam, The Netherlands — A rapid and accurate DHPLC assay for determination of apolipoprotein E genotypes has been developed by researchers from the Department of Medical Genetics, School of Basic Medical Sciences, Southern Medical Universi
9 January 2008
Memantine and Alzheimer's Disease: Does it do what it says on the tin?
Amsterdam — In a study published this month in the Journal of Alzheimer’s Disease, researchers from the University of Aberdeen report that the drug memantine, used for the treatment of Alzheimer’s disease and praised as “the first and only representative o
15 November 2007
Binding of proteases to fibrillar amyloid protein and its inhibition by Congo red are identified
Staten Island, NY—Scientists from the New York State Institute for Basic Research in Developmental Disabilities (IBR) report today in the November issue of the Journal of Alzheimer’s Disease that the proteases neprilysin and insulysin bind to fibrillar amyloid bet
15 November 2007
Biomarkers for Alzheimer's disease can be trusted in clinical trials
Göteborg, Sweden, 15 November 2007 -- The best-established biomarkers for Alzheimer’s disease have a low natural variation over two years. The results speak for the inclusion of these biomarkers in clinical trials of novel drugs against Alzheimer’s disease.
15 November 2007
Journal of Alzheimer's Disease special issue explores multifaceted aspects of AD: From social to molecular problems
Amsterdam — A recently published special issue of the Journal of Alzheimer's Disease contains the contributions from experts in the field of aging, dementia and Alzheimer’s disease, who attended the “Fourth Annual Meeting on Brain aging and Dementia: From successfu
30 September 2007
New Study Finds that Testosterone May Reverse Effects of Alzheimer's Disease
An Edith Cowan University (ECU) study has found that testosterone replacement therapy lowers the levels of the toxic Alzheimer’s disease protein, beta amyloid, in an animal model and in a pilot study in humans.
Pages
